Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne C Mountford

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 5, 2011
In vitro production of red blood cellsJoanne C Mountford, Marc Turner
Journal of Translational Medicine|September 22, 2020
The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019Maurice A Canham, John D M Campbell, Joanne C Mountford
Methods in Molecular Biology (Clifton, N.J.)|October 28, 2017
Good Manufacturing Practice (GMP) Translation of Advanced Cellular Therapeutics: Lessons for the Manufacture of Erythrocytes as Medicinal ProductsNeil W A McGowan, John D M Campbell, Joanne C Mountford
Blood|November 6, 2004
Punish the parent not the progenyLucy J Elrick, Heather G Jorgensen, Joanne C Mountford, et al.
Human Gene Therapy|February 11, 2005
All-trans retinoic acid increases transgene expression in MSCV-transduced cells, via a mechanism that is retinoid receptor dependent but independent of cellular differentiationJoanne C Mountford, Elio F Vanin, Rachel E Hayden, et al.
Blood|April 22, 2006
Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylateNiove E Jordanides, Heather G Jorgensen, Tessa L Holyoake, et al.
Stem Cells Translational Medicine|July 13, 2016
High-Efficiency Serum-Free Feeder-Free Erythroid Differentiation of Human Pluripotent Stem Cells Using Small MoleculesEmmanuel N Olivier, Lamin Marenah, Angela McCahill, et al.
Experimental Hematology|April 28, 2009
Inhibition of MDR1 does not sensitize primitive chronic myeloid leukemia CD34+ cells to imatinibSophia Hatziieremia, Niove E Jordanides, Tessa L Holyoake, et al.
Regenerative Medicine|May 12, 2010
Red blood cells from pluripotent stem cells for use in transfusionJoanne C Mountford, Emmanuel Olivier, Niove E Jordanides, et al.
Blood|January 11, 2007
Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cellsHeather G Jørgensen, Elaine K Allan, Niove E Jordanides, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 5, 2011
In vitro production of red blood cellsJoanne C Mountford, Marc Turner
Journal of Translational Medicine|September 22, 2020
The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019Maurice A Canham, John D M Campbell, Joanne C Mountford
Methods in Molecular Biology (Clifton, N.J.)|October 28, 2017
Good Manufacturing Practice (GMP) Translation of Advanced Cellular Therapeutics: Lessons for the Manufacture of Erythrocytes as Medicinal ProductsNeil W A McGowan, John D M Campbell, Joanne C Mountford
Blood|November 6, 2004
Punish the parent not the progenyLucy J Elrick, Heather G Jorgensen, Joanne C Mountford, et al.
Human Gene Therapy|February 11, 2005
All-trans retinoic acid increases transgene expression in MSCV-transduced cells, via a mechanism that is retinoid receptor dependent but independent of cellular differentiationJoanne C Mountford, Elio F Vanin, Rachel E Hayden, et al.
Blood|April 22, 2006
Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylateNiove E Jordanides, Heather G Jorgensen, Tessa L Holyoake, et al.
Stem Cells Translational Medicine|July 13, 2016
High-Efficiency Serum-Free Feeder-Free Erythroid Differentiation of Human Pluripotent Stem Cells Using Small MoleculesEmmanuel N Olivier, Lamin Marenah, Angela McCahill, et al.
Experimental Hematology|April 28, 2009
Inhibition of MDR1 does not sensitize primitive chronic myeloid leukemia CD34+ cells to imatinibSophia Hatziieremia, Niove E Jordanides, Tessa L Holyoake, et al.
Regenerative Medicine|May 12, 2010
Red blood cells from pluripotent stem cells for use in transfusionJoanne C Mountford, Emmanuel Olivier, Niove E Jordanides, et al.
Blood|January 11, 2007
Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cellsHeather G Jørgensen, Elaine K Allan, Niove E Jordanides, et al.
Pageof 5